Bank of New York Mellon Corp - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 87 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$569,000
+37.4%
123,329
+4.1%
0.00%
Q4 2018$414,000
-62.2%
118,434
+8.9%
0.00%
Q3 2018$1,096,000
+39.3%
108,7450.0%0.00%
Q2 2018$787,000
+20.5%
108,745
+0.8%
0.00%
Q1 2018$653,000
-37.4%
107,910
-0.4%
0.00%
Q4 2017$1,043,000
-25.7%
108,393
-31.4%
0.00%
Q3 2017$1,403,000
-29.1%
158,021
+1.0%
0.00%
-100.0%
Q2 2017$1,980,000
+21.8%
156,471
+1.2%
0.00%
Q1 2017$1,625,000
-62.9%
154,595
-67.5%
0.00%
-100.0%
Q4 2016$4,380,000
-33.2%
476,045
-14.4%
0.00%
-50.0%
Q3 2016$6,559,000
+0.1%
556,310
+9.9%
0.00%0.0%
Q2 2016$6,550,000
-15.7%
506,159
+4.2%
0.00%0.0%
Q1 2016$7,766,000
+84.1%
485,713
+229.7%
0.00%
+100.0%
Q4 2015$4,218,000
+14.7%
147,321
+14.0%
0.00%0.0%
Q3 2015$3,677,000
-30.4%
129,218
-12.1%
0.00%0.0%
Q2 2015$5,283,000
+40.4%
147,053
+127.1%
0.00%0.0%
Q1 2015$3,764,000
+41.0%
64,753
+2.3%
0.00%0.0%
Q4 2014$2,669,000
+29.8%
63,309
+19.4%
0.00%0.0%
Q3 2014$2,056,000
-26.8%
53,018
-41.0%
0.00%
Q2 2014$2,810,000
+60.7%
89,928
+113.0%
0.00%
Q1 2014$1,749,000
+60.9%
42,223
+50.4%
0.00%
Q4 2013$1,087,000
-62.3%
28,074
-65.9%
0.00%
Q3 2013$2,880,000
+1361.9%
82,294
+477.9%
0.00%
Q2 2013$197,00014,2400.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders